Sulphone induced exfoliative dermatitis and hepatitis.
Exfoliative dermatitis associated with hepatitis has been reported in leprosy patients taking dapsone in daily dosage of 200 mg daily or more previously. This report concerns a 40 year-old-female who developed exfoliative dermatitis and hepatitis six weeks after starting dapsone in daily dosage of 100 mg for treatment of leprosy. She responded dramatically to administration of corticosteroids.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003622:Dapsone / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D003622:Dapsone